Literature DB >> 12766589

Special types of invasive breast cancer, with clinical implications.

David L Page1.   

Abstract

Analysis of invasive breast cancers by histopathology has generally revolved around the analysis of individual characteristics such as nuclear pleomorphism and/or gland formation (grading) or categorization by specific histologic patterns (special type carcinomas). Recognition of special types of invasive breast carcinoma allows for the identification of women with an extremely good prognosis often approaching or equaling that of the general population of the same age (with unique problems for medullary). The distinguishing features of special types of breast cancer are present in complete or classic form in the pure examples of these cases, and the features recognizing these types may be present in lesser degrees in many carcinomas of no special type or not otherwise specified in which they often have important clinical correlates other than strong indicators of survival, such as recognizing the diffusely invasive feature of lobular and lobular-like cancers. Many other features have been noted as contenders for types of breast cancer (such as squamous, cystic, clear cell, histiocytoid, and lipid rich). These terms are not discussed here because they have no special clinical correlates relevant to diagnosis or prognosis. It should be reemphasized here that combined histologic grade (Nottingham system favored) with nuclear, glandular, and mitotic evaluation is expected by most authorities for clarification of diagnosis in all but rare, pure medullary cancers. (5, 13, 14, 27) The Nottingham grade 11 interacts with nodal status to produce a very strong prognostic index. The mitotic count may be the most important part of the grading system, certainly for prognosis within 5 years of diagnosis. (22, 26)

Entities:  

Mesh:

Year:  2003        PMID: 12766589     DOI: 10.1097/00000478-200306000-00016

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  25 in total

1.  Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.

Authors:  Melinda E Sanders; Eduardo C Dias; Baogang J Xu; James A Mobley; Dean Billheimer; Heinrich Roder; Julia Grigorieva; Mitchell Dowsett; Carlos L Arteaga; Richard M Caprioli
Journal:  J Proteome Res       Date:  2008-04-04       Impact factor: 4.466

2.  Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.

Authors:  Edith A Perez; Karla V Ballman; Kathy S Tenner; E Aubrey Thompson; Sunil S Badve; Helen Bailey; Frederick L Baehner
Journal:  JAMA Oncol       Date:  2016-01       Impact factor: 31.777

3.  A methyl-deviator epigenotype of estrogen receptor-positive breast carcinoma is associated with malignant biology.

Authors:  J Keith Killian; Sven Bilke; Sean Davis; Robert L Walker; Erich Jaeger; M Scott Killian; Joshua J Waterfall; Marina Bibikova; Jian-Bing Fan; William I Smith; Paul S Meltzer
Journal:  Am J Pathol       Date:  2011-05-13       Impact factor: 4.307

4.  Sentinel Node Biopsy in Special Histologic Types of Invasive Breast Cancer.

Authors:  Montserrat Solà; Mireia Recaj; Eva Castellà; Pere Puig; Josep Maria Gubern; Juan Francisco Julian; Manel Fraile
Journal:  J Breast Health       Date:  2016-04-01

Review 5.  Breast cancer - one term, many entities?

Authors:  Nicholas R Bertos; Morag Park
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

6.  Value of frozen section and primary tumor factors in determining sentinel lymph node spread in early breast carcinoma.

Authors:  Rajshekhar C Jaka; Shabber S Zaveri; S P Somashekhar; R V Parameswaran
Journal:  Indian J Surg Oncol       Date:  2010-08-07

7.  Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified.

Authors:  Seho Park; Jaseung Koo; Joo-Hee Kim; Woo Ick Yang; Byeong-Woo Park; Kyong Sik Lee
Journal:  J Korean Med Sci       Date:  2010-02-19       Impact factor: 2.153

8.  Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Authors:  Julio E Celis; Teresa Cabezón; José M A Moreira; Pavel Gromov; Irina Gromova; Vera Timmermans-Wielenga; Takuji Iwase; Futoshi Akiyama; Naoko Honma; Fritz Rank
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

9.  Rare breast neoplasms: is there any peculiar feature on magnetic resonance mammography?

Authors:  A Linda; V Londero; F Mazzarella; C Zuiani; M Bazzocchi
Journal:  Radiol Med       Date:  2007-09-20       Impact factor: 3.469

10.  Elastographic features of triple negative breast cancers.

Authors:  Martina Džoić Dominković; Gordana Ivanac; Tomislav Kelava; Boris Brkljačić
Journal:  Eur Radiol       Date:  2015-08-01       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.